Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Kalaris Therapeutics (KLRS) Income from Continuing Operations (2019 - 2020)

Kalaris Therapeutics (KLRS) has 2 years of Income from Continuing Operations data on record, last reported at 24821000.0 in Q4 2020.

  • For Q4 2020, Income from Continuing Operations fell 180.78% year-over-year to 24821000.0; the TTM value through Dec 2020 reached 69979000.0, changed N/A, while the annual FY2024 figure was 58769000.0, 131.64% down from the prior year.
  • Income from Continuing Operations reached 24821000.0 in Q4 2020 per KLRS's latest filing, down from 23788000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 7697000.0 in Q3 2019 and bottomed at 24821000.0 in Q4 2020.